Bradley R. Salonen

ORCID: 0000-0002-1981-5045
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Clinical Nutrition and Gastroenterology
  • Central Venous Catheters and Hemodialysis
  • Long-Term Effects of COVID-19
  • Nutrition and Health in Aging
  • Dialysis and Renal Disease Management
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • COVID-19 Clinical Research Studies
  • COVID-19 and Mental Health
  • Abdominal Surgery and Complications
  • Diet and metabolism studies
  • Electrolyte and hormonal disorders
  • Pharmaceutical studies and practices
  • Cardiac, Anesthesia and Surgical Outcomes
  • Child Nutrition and Feeding Issues
  • COVID-19 and healthcare impacts
  • Hemodynamic Monitoring and Therapy
  • SARS-CoV-2 and COVID-19 Research
  • Musculoskeletal pain and rehabilitation
  • Antibiotics Pharmacokinetics and Efficacy
  • Metabolism and Genetic Disorders
  • Childhood Cancer Survivors' Quality of Life
  • Intestinal Malrotation and Obstruction Disorders
  • Frailty in Older Adults
  • Ergonomics and Musculoskeletal Disorders
  • Health, psychology, and well-being

Mayo Clinic in Arizona
2016-2025

WinnMed
2017-2024

Mayo Clinic
2017-2024

Vanderbilt University Medical Center
2023

Cleveland Clinic
2023

General Department of Preventive Medicine
2022

Mayo Clinic in Florida
2016-2021

To describe the clinical data from first 108 patients seen in Mayo Clinic post-COVID-19 care clinic (PCOCC).After Institutional Review Board approval, we reviewed charts of between January 19, 2021, and April 29, PCOCC abstracted electronic medical record into a standardized database to facilitate analysis. Patients were grouped phenotypes by expert review.Most our female (75%; 81/108), median age at presentation was 46 years (interquartile range, 37 55 years). All had post-acute sequelae...

10.1016/j.mayocp.2021.11.033 article EN cc-by Mayo Clinic Proceedings 2022-02-05

Objective To develop and implement criteria for description of post COVID syndrome based on analysis patients presenting evaluation at Mayo Clinic Rochester between November 2019 August 2020. Methods A total 465 with a history testing positive COVID-19 were identified their medical records reviewed. After thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases persistent central sensitization (CS) symptoms persisting after resolution acute COVID-19, herein referred to...

10.1177/21501327211030826 article EN cc-by-nc Journal of Primary Care & Community Health 2021-01-01

Background: Over 30% of patients with COVID-19 have persistent symptoms that last beyond 30 days and referred to as Long COVID. COVID has been associated a elevation in peripheral cytokines including interleukin-6, interleukin-1β, tumor necrosis factor-α. This study reports cytokine profiles our clinic across SARS-COV-2 variant epochs. Methods: The clinical panel was analyzed during periods were stratified according epoch. 4 epochs defined as: (1) wild-type through alpha, (2)...

10.1177/21501319241254751 article EN cc-by-nc Journal of Primary Care & Community Health 2024-01-01

Objective Persistent post-COVID symptoms are estimated to occur in up 10% of patients who have had COVID-19. These lingering may persist for weeks months after resolution the acute illness. This study aimed add insight into our understanding certain post-acute conditions and clinical findings. The primary purpose was determine persistent post COVID impairments prevalence characteristics by collecting illness data utilizing Patient-Reported Outcomes Measurement Information System (PROMIS ® )....

10.1177/21501327211030413 article EN cc-by-nc Journal of Primary Care & Community Health 2021-01-01

Objectives: The purpose of the present study was to assess and describe severity symptoms reported by Covid-19 positive patients who vaped (smoked e-cigarettes) when compared those did not vape or smoke at time diagnosis Covid-19. Methods: Patients from this are a well-characterized patient cohort collected Mayo Clinic between March 1, 2020 February 28, 2021; with confirmed COVID-19 defined as result on reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays nasopharyngeal swab...

10.1177/21501319211062672 article EN cc-by-nc Journal of Primary Care & Community Health 2022-01-01

Objective: Multicancer Detection (MCD) tests, such as the GRAIL Galleri, offer a novel approach to cancer screening by detecting cancer-specific methylation patterns in cell-free DNA through single blood sample. This study evaluated an 18-month implementation of MCD testing tertiary ambulatory internal medicine clinic. Patients and Methods: Between June 2022 November 2023, 2244 asymptomatic (without symptoms attributed cancer) patients underwent testing. The focused on operational workflows,...

10.1177/21501319251329290 article EN cc-by-nc Journal of Primary Care & Community Health 2025-01-01

Abstract Postural orthostatic tachycardia syndrome (POTS) presents heterogeneously and is diagnosed when appropriate symptoms are present in conjunction with a heart rate increase of at least 30 beats-per-minute upon standing without hypotension. Much the current understanding POTS based on clinical expertise, particularly regarding phenotypes their potential role targeting pharmacologic treatment. This study describes symptom presentation by subspecialty clinic. Data was collected...

10.1038/s41598-023-50886-8 article EN cc-by Scientific Reports 2024-01-02

To study the impact of a 60-day pilot an innovative virtual-care model using general internal medicine physicians and nurses to respond rapidly more than 1200 coronavirus disease-2019 (COVID-19)-positive nasopharyngeal polymerase chain reaction tests.The current was approved by Mayo Clinic COVID-19 Research Committee Institutional Review Board. The data for all SARS-CoV-2-positive patients treated our team were entered into prospectively maintained research electronic capture database. We...

10.1016/j.mayocpiqo.2020.12.003 article EN cc-by-nc-nd Mayo Clinic Proceedings Innovations Quality & Outcomes 2020-12-17

Abstract Background : Although home parenteral nutrition (HPN) is lifesaving for patients with chronic intestinal failure (IF), long‐term use can be associated complications such as infections, metabolic abnormalities, and IF–associated liver disease (IFALD). The key to treatment of many these prevention. Guidelines recommend avoidance overfeeding, oral/enteral if possible, cyclic PN, maintaining dose soybean oil (SO) intravenous lipid emulsion (ILE) <1 g/kg/day preventive strategies...

10.1002/jpen.1526 article EN Journal of Parenteral and Enteral Nutrition 2019-03-12

Abstract Background Patients with chronic intestinal failure who require long‐term parenteral nutrition rely on central venous catheters (CVCs) for access to and hydration. With prolonged use, complications such as line–associated bloodstream infection (CLABSI), damage CVC, thrombosis (CVT) can threaten the availability of life‐preserving access. Because this, all efforts should be made preserve CVCs techniques catheter salvage in case CLABSI repair when damaged. The present study was...

10.1002/jpen.1611 article EN Journal of Parenteral and Enteral Nutrition 2019-06-02

Dysfunction in smell or taste is well recognized phenomenon patients infected with SARS-CoV-2. This study aimed to quantify the incidence and associated co-morbidities of reported olfactory gustatory dysfunction who tested positive for

10.1002/lio2.911 article EN Laryngoscope Investigative Otolaryngology 2022-10-21

Abstract Purpose The increased prevalence of home enteral nutrition (HEN), reemergence blenderized tube feeding (BTF), and conversion connectors to the ISO 80369‐3 standard are creating a significant need better understand practices HEN population. A cross‐sectional survey current consumers was conducted evaluate demographics consumers, including formulas tubes being used. Methods In order disseminate wide range we partnered with private infusion companies (Coram Pediatric Home Services)...

10.1002/jpen.1510 article EN Journal of Parenteral and Enteral Nutrition 2019-02-07

High-ω-6 polyunsaturated fatty acids (PUFAs) are noted to contribute development of intestinal failure-associated liver disease (IFALD) in home parenteral nutrition (HPN). Fish oil (FO) has been added latest generation lipid injectable emulsion (ILE) increase ω-3:ω-6 PUFA ratio; however, appropriate dose FO treat IFALD is unknown.After approval exclusive ILE the US for pediatric patients, we 2 adult patients with ongoing despite transition mixed-oil (MO) ILE. They were transitioned off-label...

10.1002/ncp.10581 article EN Nutrition in Clinical Practice 2020-09-24
Coming Soon ...